This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lionaki, S Articles by Boletis, J. Search for Related Content PubMed PubMed Citation Articles by Lionaki, S Articles by Boletis, J. Pubmed/NCBI databases Medline Plus Health Information Kidney Transplantation Lupus Social Bookmarking                   What's this?

Kidney transplantation in lupus patients: a case–control study from a single centre

Nephrology and Transplantation Department, Laiko General Hospital, Athens, Greece, sofialionaki{at}yahoo.com

PP Kapitsinou

Department of Pathophysiology,University of Athens, Athens, Greece

A Iniotaki

Department of Immunology and Histocompatibility, General State Hospital of Athens, Athens, Greece

A Kostakis

Department of Surgery, University of Athens, Medical School, Athens, Greece

HM Moutsopoulos

Department of Pathophysiology,University of Athens, Athens, Greece

JN Boletis

Nephrology and Transplantation Department, Laiko General Hospital, Athens, Greece

This study was conducted to determine kidney transplantation (KTx) outcomes for Greek patients with renal failure caused by lupus nephritis (LN) compared with matched controls, kidney recipients with other causes of end-stage renal disease (ESRD). Twenty-six patients with systemic lupus erythematosus (SLE) subjected to 26 kidney transplants were studied. For comparative purposes a case–control group was selected, matched for gender, source of donor, age and time of KTx. Patient and graft survival estimates were calculated with the Kaplan–Meier product limit estimator and survival estimates were compared with the log-rank test. All patients received cyclosporine or tacrolimus in combination with azathioprine or mycophenolate mofetil for chronic immunosuppression in addition to steroids. Fourteen transplants were from living-related donors and 12 were from deceased donors. The graft survival rates for lupus patients were 88% at 1 year, 67% at 5 years, 38% at 10 years, poorer than the control survival rates of 92%, 92% and 84% (P = 0.004). Patient survival in the lupus group did not differ from that of the controls. Survival in the lupus group was 92% at 1 year, 77% at 5 years and 77% at 10 years vs. 96%, 92% and 92% (P = 0.26). Chronic allograft nephropathy was the major cause of graft loss. Recurrent LN was detected in two patients, but only one lead to graft failure. SLE patients compared with controls had significantly higher rates of hypertension, cardiovascular disease, infections and malignancies. Compared with matched controls, SLE patients had inferior but still satisfactory graft survival rates, whereas patient survival rates were similar.

Key Words: lupus nephritis • systemic lupus erythematosus

Lupus, Vol. 17, No. 7, 670-675 (2008)
DOI: 10.1177/0961203308089430


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?